RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

OBJECTIVE: The hypothesis that been set forward that use of Renin Angiotensin Aldosterone System (RAAS) inhibitors is associated with COVID−19 severity. We set-up a multicenter Italian collaboration (CORIST Project, ClinicalTrials.gov ID: NCT04318418) to retrospectively investigate the relationship...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521934/
https://www.ncbi.nlm.nih.gov/pubmed/32992048
http://dx.doi.org/10.1016/j.vph.2020.106805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521934/
https://www.ncbi.nlm.nih.gov/pubmed/32992048
http://dx.doi.org/10.1016/j.vph.2020.106805

Ejemplares similares